Reports for fondation Innovative Medicines for Tuberculosis (iM4TB)
Credit rating information
Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.Find out more
Economic information
Comprehensive information about the economic situation of a company.Find out more
Payment collection information
Overview of current and past debt enforcement proceedings.Find out more
Company dossier as PDF
Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.Retrieve company dossier
About fondation Innovative Medicines for Tuberculosis (iM4TB)
- fondation Innovative Medicines for Tuberculosis (iM4TB) from Lausanne operates in the sector «Research and development» and is active.
- The management has 7 active persons registered.
- The organization has last modified its commercial register entry on 28.01.2025. All previous commercial register entries are available under «Notifications».
- The reported UID is the following: CHE-270.892.523.
Management (7)
newest members of the Foundation Board
Benoit Lechartier,
Gabriel Clerc,
Laurent François Denis Fraisse,
Thierry Buclin,
Stewart Thomas Cole
newest authorized signatories
Benoit Lechartier,
Gabriel Clerc,
Laurent François Denis Fraisse,
Thierry Buclin,
Stewart Thomas Cole
Commercial register information
Entry in the commercial register
24.01.2014
Legal form
Foundation
Legal headquarters of the company
Ecublens (VD)
Commercial Registry Office
VD
Commercial register number
CH-550.1.143.053-2
UID/VAT
CHE-270.892.523
Sector
Research and development
Purpose (Original language)
Promouvoir et soutenir la recherche et le développement de médicaments contre la tuberculose et d'autres maladies similaires négligées liées à la pauvreté, telles que la lèpre ou l'ulcère de Buruli; coordonner le projet européen MM4TB initié le 1er février 2011 ainsi que tout projet similaire relatif à la recherche et au développement de médicaments contre la tuberculose et d'autres maladies similaires négligées liées à la pauvreté, telles que la lèpre ou l'ulcère de Buruli.
Auditor
Current auditor (1)
| Name | City | Since | Until | |
|---|---|---|---|---|
| BDO SA | Epalinges | 12.03.2020 | ||
Former auditor (1)
| Name | City | Since | Until | |
|---|---|---|---|---|
| PricewaterhouseCoopers SA | Lausanne | 29.01.2014 | 11.03.2020 | |
Other company names
Past and translated company names
- Fondation Innovative Medicines for Tuberculosis iM4TB
- fondation Innovative Medicines for Tuberculosis iM4TB
Branches (0)
Ownership structure
Holdings
Newest SOGC notifications: fondation Innovative Medicines for Tuberculosis (iM4TB)
The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications
Publication number: HR02-1006240615, Commercial Registry Office Vaud, (550)
fondation Innovative Medicines for Tuberculosis (iM4TB), à Ecublens (VD), CHE-270.892.523 (FOSC du 05.05.2021, p. 0/1005170473). Nicod Laurent Pierre n'est plus membre du conseil de fondation;
sa signature est radiée. Lechartier Benoit, de France, à Lausanne, est membre du conseil de fondation avec signature collective à deux.
Publication number: HR02-1005170473, Commercial Registry Office Vaud, (550)
fondation Innovative Medicines for Tuberculosis (iM4TB), à Ecublens (VD), CHE-270.892.523 (FOSC du 04.03.2021, p. 0/1005115850). Clerc Gabriel est nommé vice-président et signe désormais individuellement.
Publication number: HR02-1005115850, Commercial Registry Office Vaud, (550)
Fondation Innovative Medicines for Tuberculosis (iM4TB), à Ecublens (VD), CHE-270.892.523 (FOSC du 13.11.2020, p. 0/1005022706). Acte de fondation modifié le 21.01.2021.
Nouvelle graphie du nom:
fondation Innovative Medicines for Tuberculosis (iM4TB).
Hit list
Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.